ST AIA-PACK CA 125

CA 125 is a glycoprotein, an antigen that plays an important role of tumor marker or biomarker. Elevated serum levels of CA 125 are associated with greater than 80% of nonmucinous epithelial ovarian neoplasm. Elevated serum levels of CA 125 are also associated with other gynecological neoplasm's, primarily endometrium and fallopian tube carcinomas and certain tumors of the pancreas, liver, colon, breast and lung. Recent studies indicate that monitoring serial determinations of CA 125 in conjunction with chemotherapy may have clinical value in deciding proper prognosis. Studies also suggest that long term monitoring of CA 125 in patients with known ovarian carcinomas has utility in detecting early recurrence and disease progression. 

Technical specifications

Refer to the product Instruction-For-Use (IFU) for complete details.